LINK WILLIAM J PHD
SEC insider (Form 3/4/5 filer). CIK 0001228684. Director at Tarsus Pharmaceuticals, Inc. (TARS) and 2 other issuers. 27 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in IRVINE, CA.
Companies LINK WILLIAM J PHD has filed insider reports for
- Tarsus Pharmaceuticals, Inc. (TARS): Director
- RxSight, Inc. (RXST): Director
- LENSAR, Inc. (LNSR): Director
LINK WILLIAM J PHD
CIK: 0001228684
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Sep 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect201 shares- - Sep 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect11.7K shares at avg. $78.33$915K - Sep 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect759 shares at avg. $79.00$60K - Sep 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect66 shares at avg. $80.01$5K - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
806 shares- - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
3.8K shares- - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
2.4K shares- - Jun 17, 2026RXST
RxSight, Inc.
AwardDirect37K shares- - Jun 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect1.9K shares at avg. $62.94$121K - Jun 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect10.6K shares at avg. $61.97$655K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 |  TARS Tarsus Pharmaceuticals, Inc. | Exercise | 201 | - | $0 | Direct |
| Sep 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 11,675 | $78.33 | $914,503 | Direct |
| Sep 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 759 | $79.00 | $59,961 | Direct |
| Sep 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 66 | $80.01 | $5,281 | Direct |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Restricted Stock Units | 806 | - | - | Direct |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 3,837 | - | - | Direct |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Restricted Stock Units | 2,417 | - | - | Direct |
| Jun 17, 2026 |  RXST RxSight, Inc. | Award | 37,037 | - | $0 | Direct |
| Jun 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 1,928 | $62.94 | $121,348 | Direct |
| Jun 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 10,572 | $61.97 | $655,147 | Direct |
1-10 of 27 transactions